SynthesisFrontiers in pharmacology2025

Safety profile and dose-dependent adverse events of upadacitinib in randomized clinical trials: a systematic review and meta-analysis.

Cong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.